Literature DB >> 22889793

A case of multimodality multiparametric 11C-choline PET/MR for biopsy targeting in prior biopsy-negative primary prostate cancer.

Toshiki Takei1, Michael Souvatzoglou, Ambros J Beer, Alexander Drzezga, Sybille Ziegler, Ernst J Rummeny, Markus Schwaiger, Matthias Eiber.   

Abstract

We introduce the case of a 70-years-old man with an elevated level of prostate-specific antigen and prior negative biopsy. For targeting rebiopsy, the patient underwent C-choline PET/CT and subsequent PET/MR. Both the high uptake in PET and the abnormal findings in MR gave strong evidence for prostate cancer at the ventral periphery of the right apex. This location is sometimes not covered by routine sextant biopsy. The following targeted rebiopsy was positive for prostate cancer. This case indicates the potential role of PET/MR for identifying primary prostate cancer because of its high soft tissue contrast and the possibility of a multimodality approach.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22889793     DOI: 10.1097/RLU.0b013e31825b23a6

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  7 in total

Review 1.  PET/MR in prostate cancer: technical aspects and potential diagnostic value.

Authors:  Michael Souvatzoglou; Matthias Eiber; Axel Martinez-Moeller; Sebastian Fürst; Konstantin Holzapfel; Tobias Maurer; Sibylle Ziegler; Stephan Nekolla; Markus Schwaiger; Ambros J Beer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-24       Impact factor: 9.236

Review 2.  68Ga-PSMA-PET: added value and future applications in comparison to the current use of choline-PET and mpMRI in the workup of prostate cancer.

Authors:  Simona Malaspina; Ugo De Giorgi; Jukka Kemppainen; Angelo Del Sole; Giovanni Paganelli
Journal:  Radiol Med       Date:  2018-08-16       Impact factor: 3.469

Review 3.  PET Molecular Imaging-Directed Biopsy: A Review.

Authors:  Baowei Fei; David M Schuster
Journal:  AJR Am J Roentgenol       Date:  2017-05-15       Impact factor: 3.959

4.  Cardiac PET/MRI enters the clinical arena! Finally….

Authors:  C Rischpler; N Langwieser; S G Nekolla
Journal:  J Nucl Cardiol       Date:  2016-09-23       Impact factor: 5.952

Review 5.  Integrated whole body MR/PET: where are we?

Authors:  Hye Jin Yoo; Jae Sung Lee; Jeong Min Lee
Journal:  Korean J Radiol       Date:  2015-01-09       Impact factor: 3.500

Review 6.  Metabolic Imaging in Prostate Cancer: Where We Are.

Authors:  Claudia Testa; Cristian Pultrone; David Neil Manners; Riccardo Schiavina; Raffaele Lodi
Journal:  Front Oncol       Date:  2016-11-09       Impact factor: 6.244

7.  New prospects for PET in prostate cancer imaging: a physicist's viewpoint.

Authors:  Maurizio Conti
Journal:  EJNMMI Phys       Date:  2014-09-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.